Comparison of Patient Outcomes Before and After Switching From Warfarin to a Direct Oral Anticoagulant Based on Time in Therapeutic Range Guideline Recommendations

Authors

Brian Haymart
Geoffrey D. Barnes
Xiaowen Kong
Mona Ali
Eva Kline-Rogers
Deborah DeCamillo
Scott Kaatz, Henry Ford HealthFollow

Recommended Citation

Haymart B, Barnes GD, Kong X, Ali M, Kline-Rogers E, DeCamillo D, and Kaatz S. Comparison of Patient Outcomes Before and After Switching From Warfarin to a Direct Oral Anticoagulant Based on Time in Therapeutic Range Guideline Recommendations. JAMA Netw Open 2022; 5(7):e2222089.

Document Type

Article

Publication Date

7-1-2022

Publication Title

JAMA Netw Open

Medical Subject Headings

Anticoagulants; Humans; Rivaroxaban; Warfarin

PubMed ID

35834255

Volume

5

Issue

7

First Page

2222089

Last Page

2222089